Trademark Overview
On Tuesday, July 7, 2026, a trademark application was filed for SKYSTAR with the United States Patent and Trademark Office. The USPTO has given the SKYSTAR trademark a serial number of 99926740. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 7, 2026. This trademark is owned by Skyhawk Therapeutics, Inc.. The SKYSTAR trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis; pharmaceuticals used in the treatment of cancers, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis